Retrospective review reveals differential treatment responses in occipital migraine patients, suggesting tailored strategies are needed.
Introduction: In this study, we aimed to compare clinical characteristics and treatment responses in patients with migraine with occipital pain and those with non-occipital pain. We hypothesized that the area of pain could influence clinical features and treatment responses. Methods: We conducted a retrospective review of patients diagnosed with episodic or chronic migraine who attended a Neurology (Headache) outpatient clinic between January 2022 and December 2024. Patients were divided into two groups: Group 1 (People with migraine with occipital pain) and Group 2 (People with migraine with non-occipital pain). Data were collected on demographic characteristics, clinical features, and treatment responses. Results: A total of 100 patients were enrolled, with 50 included in Group 1 [39 patients (78%) with episodic migraine; 40 (80%) females], and 50 patients included in Group 2 [40 patients (80%) with episodic migraine; 43 (86%) females]. No significant difference was found in gender distribution (p=0.603), age of migraine onset (p=0.904), or time until diagnosis (p=0.205). Group 1 had more frequent bilateral pain (50% vs 38%, p=0.003) and a higher mean of migraine days per month (11 vs 6, p=0.004). Similar proportions of patients started oral preventive treatment (70% vs 80%, p=0.248). In Group 1, the most prescribed drug was amitriptyline, while in Group 2, it was topiramate. Group 1 had higher treatment failure rates than Group 2 (70% vs 31%, p<0.001). After adjusting for monthly migraine frequency, occipital pain remained independently associated with a poorer response to preventive treatment (adjusted OR = 0.33; 95% CI: 0.14–0.77; p=0.01). Conclusion: Patients with occipital migraine experience more bilateral pain, migraine frequency, and higher treatment failure rates. These findings suggest the need for tailored treatment strategies based on migraine pain localization.
No takes yet. Share an insight, caveat, or question.
Cabral et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: